Status:
RECRUITING
Electrical Vestibular Nerve Stimulation (VeNS) as a Treatment for Anxiety in Adolescents
Lead Sponsor:
Neurovalens Ltd.
Conditions:
General Anxiety Disorder
Eligibility:
All Genders
12-17 years
Phase:
NA
Brief Summary
Trial title: A Randomized, Double-blind Sham-controlled Clinical Trial to Evaluate The Efficacy of Electrical Vestibular Stimulation (VeNS), Compared to a Sham Control For The Management Of Anxiety in...
Detailed Description
This double blind randomized controlled trial will enroll up to 60 subjects and will be conducted at the BGS MCH Hospital. The study will be randomized for a 8-week period with a 1:1 active to sham de...
Eligibility Criteria
Inclusion
- Signed Informed Consent
- Signed Assent Form
- Male or female, age ≥ 12 years and ≤ 17 years at the time of signing informed consent
- GAD-7 score of \>/=10 at screening
- Can speak and read English
- Ability and willingness to travel to the clinic to complete all study visits, stimulation sessions and procedures
- Ability and willingness to adhere to 30 minutes usage of the device 5 days per week for the duration of the trial at clinic
- Agree not to undergo any extreme lifestyle changes during the duration of the study that could impact anxiety e.g. dietary or exercise changes
Exclusion
- GAD-7 score of \< 10 at screening
- Medication for anxiety
- Starting a new antidepressant during the study, or on an unstable dose of antidepressants within 3 months of starting study
- Risk of persistent self-harm or suicide
- Diagnosis or history of bipolar disorder
- History of a current psychotic disorder such as schizophrenia or other non-mood disorder psychosis
- Diagnosis of substance use disorder or dependence
- Use of recreational drugs (e.g nalgesics, depressants, stimulants, and hallucinogens). Subject can enrol after a washout period of 30 days
- History of diagnosed cognitive impairment / disorder such as delirium or dementia
- Previous diagnosis of a chronic viral infection, for example hepatitis or HIV.
- History of stroke or head injury requiring intensive care or neurosurgery
- Presence of permanently implanted battery-powered medical device or stimulator (e.g., pacemaker, implanted defibrillator, deep brain stimulator, vagal nerve stimulator, etc.)
- History of epilepsy
- History of severe tinnitus or vertigo
- History of skin breakdown, eczema or other dermatological condition (e.g. psoriasis) affecting the skin behind the ears.
- History or presence of malignancy within the last year (except basal and squamous cell skin cancer and in-situ carcinomas)
- History of vestibular dysfunction or another inner ear disease
- Regular use (more than twice a month) of antihistamine medication within the last 6 months
- Diagnosis of active migraines
- Previous use of Modius device or any VeNS device
- Participation in other clinical trials sponsored by Neurovalens
- Any other medical condition, or medication use, that in the opinion of the PI is likely to make the subject refractory to VeNS.
- Failure to use device daily during trial participation (no more than 7 consecutive days usage drop without reasonable explanation)
Key Trial Info
Start Date :
September 8 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06956105
Start Date
September 8 2025
End Date
June 1 2026
Last Update
January 6 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
BGS MCH Hospital
Bangalore, India